Clinical Trials Browser

Phase 1 × SCLC × sintilimab × Clear all

NCT05026593 2023-07-19

A Study of IBI110 in Combination With Sintilimab and Chemotherapy in Patients With Untreated Extensive-Stage Small Cell Lung Cancer

Phase 1 Completed

SCLC